ADIL:Adial Pharmaceuticals Inc Snapshot | Charting | News | Options
$1.55 NASDAQ 8:30a ET
May 15 '24 		Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on ADIL
    No News Available
    Adial Pharmaceuticals Granted Key Patent from the United States Paten...
    8:30a ET April 22 '24 GlobeNewswire
    Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlightin...
    8:30a ET April 10 '24 GlobeNewswire
    Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and ...
    8:30a ET April 2 '24 GlobeNewswire
    Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million...
    7:00p ET March 1 '24 GlobeNewswire
    Adial Pharmaceuticals Awarded New Patent from the United States Paten...
    9:30a ET February 28 '24 GlobeNewswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.